$VNRX Income Statement | Understand Stock

$VNRX

$0.18 +$0.00 (2.58%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Royalty
Service
Product
Total Revenues
Operating Expenses
Research and development
General and administrative
Sales and marketing
Total Operating Expenses
Operating Loss
Grant income
(Loss)/Gain on disposal of fixed assets
Other Income (Expenses)
Grant income
Loss on disposal of fixed assets
Gain /( Loss) on disposal of fixed assets
Interest income
Interest expense
Amortization of debt discount
Gain on change in fair value of warrant liability
Gain on change in fair value of derivative liability
Total Other Income
Total Other Income (Expenses)
Net Loss
Net Loss attributable to Non-Controlling Interest
Net Loss attributable to VolitionRx Limited Stockholders

Net Loss attributable to VolitionRx Limited Stockholders
Net Loss attributable to Non-Controlling Interest
Other Comprehensive Income (Loss)
- Basic and Diluted
Net Comprehensive Loss
Net Loss Per Share - Basic and Diluted attributable to VolitionRx Limited Stockholders
Foreign currency translation adjustments

Net Comprehensive Loss
Net Loss Per Share - Basic and Diluted attributable to VolitionRx Limited Stockholders
- Basic and Diluted
Loss Per Common Share Attributable to Common Stockholders - Basic and Diluted
Weighted Average Number of Shares Outstanding, Diluted

Comments